{"transactions":[{"id":3190786,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-31T20:15:09.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on March 29, 2021; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2024."}],"balance_after":34000,"derivative":{"exercise_price":14.45,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-20-021798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/doc4.xml","form_type":"4"}},{"id":3190785,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Common Stock","published_at":"2020-03-31T20:15:09.000Z","date":"2020-03-31","kind":"sale","acquired":false,"shares":7812,"price":15.044,"value":117523.728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.77 to $15.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":137009,"source":{"system":"sec-edgar","filing":"0001209191-20-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/doc4.xml","form_type":"4"}},{"id":3190784,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Common Stock","published_at":"2020-03-31T20:15:09.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2021; March 29, 2022; March 29, 2023; and March 29, 2024."}],"balance_after":144821,"source":{"system":"sec-edgar","filing":"0001209191-20-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/doc4.xml","form_type":"4"}},{"id":3340838,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-16T22:17:52.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":33061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option represents a right to purchase 200,000 shares. As of January 5, 2019, 150,000 stock options have vested. The remaining options vest on January 5, 2020."}],"balance_after":166939,"derivative":{"exercise_price":7.03,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":33061},"source":{"system":"sec-edgar","filing":"0001209191-19-060710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/doc4.xml","form_type":"4"}},{"id":3340837,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Common Stock","published_at":"2019-12-16T22:17:52.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":33061,"price":25.0016,"value":826577.8976,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.035, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":127821,"source":{"system":"sec-edgar","filing":"0001209191-19-060710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/doc4.xml","form_type":"4"}},{"id":3340836,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CSO, Virology Ops"}}],"security":"Common Stock","published_at":"2019-12-16T22:17:52.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":33061,"price":7.03,"value":232418.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 532, 1,000 and 39 shares acquired under the Assembly Biosciences, Inc. 2018 Employee Stock Purchase Plan on November 14, 2018, May 14, 2019 and November 14, 2019, respectively."}],"balance_after":160882,"source":{"system":"sec-edgar","filing":"0001209191-19-060710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/doc4.xml","form_type":"4"}},{"id":3568469,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T20:34:30.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2023."}],"balance_after":32500,"derivative":{"exercise_price":19.69,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001144204-19-017740","document":"tv517876_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/tv517876_4.xml","form_type":"4"}},{"id":3568468,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-04-02T20:34:30.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2020; March 29, 2021; March 29, 2022; and March 29, 2023."}],"balance_after":126250,"source":{"system":"sec-edgar","filing":"0001144204-19-017740","document":"tv517876_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/tv517876_4.xml","form_type":"4"}},{"id":3730616,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-14T21:30:49.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit (RSU) award granted on December 12, 2018 under Assembly Biosciences, Inc.'s 2018 Stock Incentive Plan pursuant to the terms of a performance-based RSU award granted to the reporting person on December 8, 2017."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001144204-18-064669","document":"tv509184_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/tv509184_form4.xml","form_type":"4"}},{"id":3752839,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-11-26T21:05:32.000Z","date":"2018-11-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On November 23, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001144204-18-061513","document":"tv507873_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/tv507873_4.xml","form_type":"4"}},{"id":3863619,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-20T20:02:01.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On July 20, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in full on August 1, 2018, assuming the Reporting Person's continuous service through August 1, 2018."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001144204-18-039137","document":"tv498898_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/tv498898_4.xml","form_type":"4"}},{"id":3978726,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-30T22:27:53.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2019; and the remaining 75% shall vest in 36 equal monthly installments, with the options becoming fully vested on March 29, 2022."}],"balance_after":30000,"derivative":{"exercise_price":49.14,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001144204-18-018346","document":"tv490031_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418018346/tv490031_4.xml","form_type":"4"}},{"id":3978725,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-30T22:27:53.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2019; March 29, 2020; March 29, 2021; and March 29, 2022."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001144204-18-018346","document":"tv490031_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418018346/tv490031_4.xml","form_type":"4"}},{"id":4111463,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-03T21:30:24.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based Restricted Stock Unit (RSU) Award dated December 8, 2017 that was granted under Assembly Biosciences, Inc.'s Amended and Restated 2014 Stock Incentive Plan. On January 1, 2018, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in full on August 1, 2018, assuming the Reporting Person's continuous service through August 1, 2018."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001144204-18-000530","document":"tv482452_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418000530/tv482452_4.xml","form_type":"4"}},{"id":4366765,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":150250,"kind":"person","name":"Colonno Richard James","position":1,"cik":"0001663018","reported_name":"Colonno Richard James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-31T20:13:48.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over two years as follows: 50% shall vest on the first anniversary of the date of grant, March 29, 2018; and the remaining 50% shall vest in 12 equal monthly installments, with the options becoming fully vested on March 29, 2019."}],"balance_after":30000,"derivative":{"exercise_price":25.34,"expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001144204-17-018198","document":"v463067_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420417018198/v463067_4.xml","form_type":"4"}}]}